Global Human Immune Globulin Intravenous Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Immune Globulin Intravenous Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Immune Globulin Intravenous by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Immune Globulin Intravenous by Country/Region, 2017, 2022 & 2028

2.2 Human Immune Globulin Intravenous Segment by Type

2.2.1 IVIg Liquid

2.2.2 IVIg Powder

2.3 Human Immune Globulin Intravenous Sales by Type

2.3.1 Global Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

2.3.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Immune Globulin Intravenous Sale Price by Type (2017-2022)

2.4 Human Immune Globulin Intravenous Segment by Application

2.4.1 Immunodeficiency

2.4.2 Autoimmune Disease

2.4.3 Acute Infection

2.5 Human Immune Globulin Intravenous Sales by Application

2.5.1 Global Human Immune Globulin Intravenous Sale Market Share by Application (2017-2022)

2.5.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Immune Globulin Intravenous Sale Price by Application (2017-2022)

3 Global Human Immune Globulin Intravenous by Company

3.1 Global Human Immune Globulin Intravenous Breakdown Data by Company

3.1.1 Global Human Immune Globulin Intravenous Annual Sales by Company (2020-2022)

3.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Company (2020-2022)

3.2 Global Human Immune Globulin Intravenous Annual Revenue by Company (2020-2022)

3.2.1 Global Human Immune Globulin Intravenous Revenue by Company (2020-2022)

3.2.2 Global Human Immune Globulin Intravenous Revenue Market Share by Company (2020-2022)

3.3 Global Human Immune Globulin Intravenous Sale Price by Company

3.4 Key Manufacturers Human Immune Globulin Intravenous Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Immune Globulin Intravenous Product Location Distribution

3.4.2 Players Human Immune Globulin Intravenous Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Immune Globulin Intravenous by Geographic Region

4.1 World Historic Human Immune Globulin Intravenous Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Immune Globulin Intravenous Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Immune Globulin Intravenous Annual Revenue by Geographic Region

4.2 World Historic Human Immune Globulin Intravenous Market Size by Country/Region (2017-2022)

4.2.1 Global Human Immune Globulin Intravenous Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Immune Globulin Intravenous Annual Revenue by Country/Region

4.3 Americas Human Immune Globulin Intravenous Sales Growth

4.4 APAC Human Immune Globulin Intravenous Sales Growth

4.5 Europe Human Immune Globulin Intravenous Sales Growth

4.6 Middle East & Africa Human Immune Globulin Intravenous Sales Growth

5 Americas

5.1 Americas Human Immune Globulin Intravenous Sales by Country

5.1.1 Americas Human Immune Globulin Intravenous Sales by Country (2017-2022)

5.1.2 Americas Human Immune Globulin Intravenous Revenue by Country (2017-2022)

5.2 Americas Human Immune Globulin Intravenous Sales by Type

5.3 Americas Human Immune Globulin Intravenous Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Immune Globulin Intravenous Sales by Region

6.1.1 APAC Human Immune Globulin Intravenous Sales by Region (2017-2022)

6.1.2 APAC Human Immune Globulin Intravenous Revenue by Region (2017-2022)

6.2 APAC Human Immune Globulin Intravenous Sales by Type

6.3 APAC Human Immune Globulin Intravenous Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Immune Globulin Intravenous by Country

7.1.1 Europe Human Immune Globulin Intravenous Sales by Country (2017-2022)

7.1.2 Europe Human Immune Globulin Intravenous Revenue by Country (2017-2022)

7.2 Europe Human Immune Globulin Intravenous Sales by Type

7.3 Europe Human Immune Globulin Intravenous Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Immune Globulin Intravenous by Country

8.1.1 Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Immune Globulin Intravenous Sales by Type

8.3 Middle East & Africa Human Immune Globulin Intravenous Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Immune Globulin Intravenous

10.3 Manufacturing Process Analysis of Human Immune Globulin Intravenous

10.4 Industry Chain Structure of Human Immune Globulin Intravenous

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Immune Globulin Intravenous Distributors

11.3 Human Immune Globulin Intravenous Customer

12 World Forecast Review for Human Immune Globulin Intravenous by Geographic Region

12.1 Global Human Immune Globulin Intravenous Market Size Forecast by Region

12.1.1 Global Human Immune Globulin Intravenous Forecast by Region (2023-2028)

12.1.2 Global Human Immune Globulin Intravenous Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Immune Globulin Intravenous Forecast by Type

12.7 Global Human Immune Globulin Intravenous Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Human Immune Globulin Intravenous Product Offered

13.1.3 Takeda Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 Grifols

13.2.1 Grifols Company Information

13.2.2 Grifols Human Immune Globulin Intravenous Product Offered

13.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Grifols Main Business Overview

13.2.5 Grifols Latest Developments

13.3 CSL

13.3.1 CSL Company Information

13.3.2 CSL Human Immune Globulin Intravenous Product Offered

13.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CSL Main Business Overview

13.3.5 CSL Latest Developments

13.4 Octapharma

13.4.1 Octapharma Company Information

13.4.2 Octapharma Human Immune Globulin Intravenous Product Offered

13.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Octapharma Main Business Overview

13.4.5 Octapharma Latest Developments

13.5 Biotest

13.5.1 Biotest Company Information

13.5.2 Biotest Human Immune Globulin Intravenous Product Offered

13.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biotest Main Business Overview

13.5.5 Biotest Latest Developments

13.6 Kedrion

13.6.1 Kedrion Company Information

13.6.2 Kedrion Human Immune Globulin Intravenous Product Offered

13.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Kedrion Main Business Overview

13.6.5 Kedrion Latest Developments

13.7 Hualan Bio

13.7.1 Hualan Bio Company Information

13.7.2 Hualan Bio Human Immune Globulin Intravenous Product Offered

13.7.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hualan Bio Main Business Overview

13.7.5 Hualan Bio Latest Developments

13.8 CNBG

13.8.1 CNBG Company Information

13.8.2 CNBG Human Immune Globulin Intravenous Product Offered

13.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CNBG Main Business Overview

13.8.5 CNBG Latest Developments

13.9 Shanghai RAAS

13.9.1 Shanghai RAAS Company Information

13.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Offered

13.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Shanghai RAAS Main Business Overview

13.9.5 Shanghai RAAS Latest Developments

13.10 CBPO

13.10.1 CBPO Company Information

13.10.2 CBPO Human Immune Globulin Intravenous Product Offered

13.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CBPO Main Business Overview

13.10.5 CBPO Latest Developments

13.11 LFB Group

13.11.1 LFB Group Company Information

13.11.2 LFB Group Human Immune Globulin Intravenous Product Offered

13.11.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 LFB Group Main Business Overview

13.11.5 LFB Group Latest Developments

13.12 BPL

13.12.1 BPL Company Information

13.12.2 BPL Human Immune Globulin Intravenous Product Offered

13.12.3 BPL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 BPL Main Business Overview

13.12.5 BPL Latest Developments

13.13 Sichuan Yuanda Shuyang

13.13.1 Sichuan Yuanda Shuyang Company Information

13.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Offered

13.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Sichuan Yuanda Shuyang Main Business Overview

13.13.5 Sichuan Yuanda Shuyang Latest Developments

14 Research Findings and Conclusion

Table 1. Human Immune Globulin Intravenous Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Immune Globulin Intravenous Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of IVIg Liquid

Table 4. Major Players of IVIg Powder

Table 5. Global Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)

Table 6. Global Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

Table 7. Global Human Immune Globulin Intravenous Revenue by Type (2017-2022) & ($ million)

Table 8. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2017-2022)

Table 9. Global Human Immune Globulin Intravenous Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)

Table 11. Global Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Table 12. Global Human Immune Globulin Intravenous Revenue by Application (2017-2022)

Table 13. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2017-2022)

Table 14. Global Human Immune Globulin Intravenous Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Human Immune Globulin Intravenous Sales by Company (2020-2022) & (K Units)

Table 16. Global Human Immune Globulin Intravenous Sales Market Share by Company (2020-2022)

Table 17. Global Human Immune Globulin Intravenous Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Human Immune Globulin Intravenous Revenue Market Share by Company (2020-2022)

Table 19. Global Human Immune Globulin Intravenous Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Human Immune Globulin Intravenous Producing Area Distribution and Sales Area

Table 21. Players Human Immune Globulin Intravenous Products Offered

Table 22. Human Immune Globulin Intravenous Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Immune Globulin Intravenous Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Human Immune Globulin Intravenous Sales Market Share Geographic Region (2017-2022)

Table 27. Global Human Immune Globulin Intravenous Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Human Immune Globulin Intravenous Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Human Immune Globulin Intravenous Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Human Immune Globulin Intravenous Sales Market Share by Country/Region (2017-2022)

Table 31. Global Human Immune Globulin Intravenous Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Human Immune Globulin Intravenous Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)

Table 34. Americas Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)

Table 35. Americas Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)

Table 37. Americas Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)

Table 38. Americas Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

Table 39. Americas Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)

Table 40. Americas Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Table 41. APAC Human Immune Globulin Intravenous Sales by Region (2017-2022) & (K Units)

Table 42. APAC Human Immune Globulin Intravenous Sales Market Share by Region (2017-2022)

Table 43. APAC Human Immune Globulin Intravenous Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Human Immune Globulin Intravenous Revenue Market Share by Region (2017-2022)

Table 45. APAC Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)

Table 46. APAC Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

Table 47. APAC Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)

Table 48. APAC Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Table 49. Europe Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)

Table 50. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)

Table 51. Europe Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)

Table 53. Europe Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)

Table 54. Europe Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

Table 55. Europe Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)

Table 56. Europe Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Human Immune Globulin Intravenous

Table 66. Key Market Challenges & Risks of Human Immune Globulin Intravenous

Table 67. Key Industry Trends of Human Immune Globulin Intravenous

Table 68. Human Immune Globulin Intravenous Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Human Immune Globulin Intravenous Distributors List

Table 71. Human Immune Globulin Intravenous Customer List

Table 72. Global Human Immune Globulin Intravenous Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Human Immune Globulin Intravenous Sales Market Forecast by Region

Table 74. Global Human Immune Globulin Intravenous Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Human Immune Globulin Intravenous Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Human Immune Globulin Intravenous Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Human Immune Globulin Intravenous Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Human Immune Globulin Intravenous Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Human Immune Globulin Intravenous Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Human Immune Globulin Intravenous Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Application (2023-2028)

Table 92. Takeda Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 93. Takeda Human Immune Globulin Intravenous Product Offered

Table 94. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Takeda Main Business

Table 96. Takeda Latest Developments

Table 97. Grifols Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 98. Grifols Human Immune Globulin Intravenous Product Offered

Table 99. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Grifols Main Business

Table 101. Grifols Latest Developments

Table 102. CSL Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 103. CSL Human Immune Globulin Intravenous Product Offered

Table 104. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. CSL Main Business

Table 106. CSL Latest Developments

Table 107. Octapharma Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 108. Octapharma Human Immune Globulin Intravenous Product Offered

Table 109. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Octapharma Main Business

Table 111. Octapharma Latest Developments

Table 112. Biotest Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 113. Biotest Human Immune Globulin Intravenous Product Offered

Table 114. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Biotest Main Business

Table 116. Biotest Latest Developments

Table 117. Kedrion Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 118. Kedrion Human Immune Globulin Intravenous Product Offered

Table 119. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Kedrion Main Business

Table 121. Kedrion Latest Developments

Table 122. Hualan Bio Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 123. Hualan Bio Human Immune Globulin Intravenous Product Offered

Table 124. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Hualan Bio Main Business

Table 126. Hualan Bio Latest Developments

Table 127. CNBG Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 128. CNBG Human Immune Globulin Intravenous Product Offered

Table 129. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. CNBG Main Business

Table 131. CNBG Latest Developments

Table 132. Shanghai RAAS Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 133. Shanghai RAAS Human Immune Globulin Intravenous Product Offered

Table 134. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Shanghai RAAS Main Business

Table 136. Shanghai RAAS Latest Developments

Table 137. CBPO Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 138. CBPO Human Immune Globulin Intravenous Product Offered

Table 139. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. CBPO Main Business

Table 141. CBPO Latest Developments

Table 142. LFB Group Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 143. LFB Group Human Immune Globulin Intravenous Product Offered

Table 144. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. LFB Group Main Business

Table 146. LFB Group Latest Developments

Table 147. BPL Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 148. BPL Human Immune Globulin Intravenous Product Offered

Table 149. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. BPL Main Business

Table 151. BPL Latest Developments

Table 152. Sichuan Yuanda Shuyang Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors

Table 153. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Offered

Table 154. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Sichuan Yuanda Shuyang Main Business

Table 156. Sichuan Yuanda Shuyang Latest Developments

List of Figures

Figure 1. Picture of Human Immune Globulin Intravenous

Figure 2. Human Immune Globulin Intravenous Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Immune Globulin Intravenous Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Immune Globulin Intravenous Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Immune Globulin Intravenous Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of IVIg Liquid

Figure 10. Product Picture of IVIg Powder

Figure 11. Global Human Immune Globulin Intravenous Sales Market Share by Type in 2021

Figure 12. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2017-2022)

Figure 13. Human Immune Globulin Intravenous Consumed in Immunodeficiency

Figure 14. Global Human Immune Globulin Intravenous Market: Immunodeficiency (2017-2022) & (K Units)

Figure 15. Human Immune Globulin Intravenous Consumed in Autoimmune Disease

Figure 16. Global Human Immune Globulin Intravenous Market: Autoimmune Disease (2017-2022) & (K Units)

Figure 17. Human Immune Globulin Intravenous Consumed in Acute Infection

Figure 18. Global Human Immune Globulin Intravenous Market: Acute Infection (2017-2022) & (K Units)

Figure 19. Global Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)

Figure 20. Global Human Immune Globulin Intravenous Revenue Market Share by Application in 2021

Figure 21. Human Immune Globulin Intravenous Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Human Immune Globulin Intravenous Revenue Market Share by Company in 2021

Figure 23. Global Human Immune Globulin Intravenous Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Human Immune Globulin Intravenous Revenue Market Share by Geographic Region in 2021

Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Region (2017-2022)

Figure 26. Global Human Immune Globulin Intravenous Revenue Market Share by Country/Region in 2021

Figure 27. Americas Human Immune Globulin Intravenous Sales 2017-2022 (K Units)

Figure 28. Americas Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)

Figure 29. APAC Human Immune Globulin Intravenous Sales 2017-2022 (K Units)

Figure 30. APAC Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)

Figure 31. Europe Human Immune Globulin Intravenous Sales 2017-2022 (K Units)

Figure 32. Europe Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Human Immune Globulin Intravenous Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)

Figure 35. Americas Human Immune Globulin Intravenous Sales Market Share by Country in 2021

Figure 36. Americas Human Immune Globulin Intravenous Revenue Market Share by Country in 2021

Figure 37. United States Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Human Immune Globulin Intravenous Sales Market Share by Region in 2021

Figure 42. APAC Human Immune Globulin Intravenous Revenue Market Share by Regions in 2021

Figure 43. China Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2021

Figure 50. Europe Human Immune Globulin Intravenous Revenue Market Share by Country in 2021

Figure 51. Germany Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Country in 2021

Figure 58. Egypt Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Human Immune Globulin Intravenous in 2021

Figure 64. Manufacturing Process Analysis of Human Immune Globulin Intravenous

Figure 65. Industry Chain Structure of Human Immune Globulin Intravenous

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles